Biogen Idec

Robert A. Hamm has been named chief operating officer of Biogen Idec. Mr. Hamm has been executive vice president, Pharmaceutical Operations & Technology at the company since 2007. In his new role, he will add Global Business Operations to his responsibilities, effective immediately. Mr. Hamm replaces Hans Peter Hasler, who is leaving the company.

“Bob has vast experience in virtually all aspects of our operations,” said Jim Mullen, BI’s chief executive officer. “His strong commercial understanding and outstanding leadership qualities make him an excellent choice to be our chief operating officer. I want to thank Hans Peter for his many years of service at Biogen Idec during a period of tremendous growth and International expansion. We wish him well.”

Mr. Hamm joined BI in 1994. He served as senior vice president, Neurology Strategic Business Unit from 2004 to 2007. He previously served in a variety of positions of increasing responsibility, including senior vice president, Europe, Africa, Canada and Middle East; vice president, Sales and Marketing; vice president, Manufacturing & Engineering; and director, Northern Europe and Distributors Markets. From 1987 to 1994, he held a variety of management positions at Syntex Laboratories Corp.